Split History
ETFs Holding APDN »    APDN Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Applied DNA Sciences is a manufacturer of deoxyribonucleic acid (DNA) for supply chain security, brand protection, law enforcement or drug or biologic applications by using its polymerase chain reaction (PCR) based manufacturing platform. Under its wholly owned subsidiary, LineaRx, Inc., Co. supplies DNA for use in the in vitro medical diagnostics, preclinical biotechnology and preclinical drug and biologic development and manufacturing markets. Co. is also engaged in preclinical and animal drug candidate development directly and with collaborators focusing on therapeutically DNA constructs manufactured via its PCR-based DNA production platform. According to our APDN split history records, Applied DNA Sciences has had 1 split.
APDN split history picture
Applied DNA Sciences (APDN) has 1 split in our APDN split history database. The split for APDN took place on November 01, 2019. This was a 1 for 40 reverse split, meaning for each 40 shares of APDN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split.

When a company such as Applied DNA Sciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the APDN split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Applied DNA Sciences shares, starting with a $10,000 purchase of APDN, presented on a split-history-adjusted basis factoring in the complete APDN split history. APDN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/20/2009
End date: 11/19/2019
Start price/share: $3.60
End price/share: $3.82
Dividends collected/share: $0.00
Total return: 6.11%
Average Annual Total Return: 0.59%
Starting investment: $10,000.00
Ending investment: $10,606.08
Years: 10.00
Date Ratio
11/01/20191 for 40
APDN is categorized under the Industrials sector; below are some other companies in the same sector that also have a history of stock splits:

APH Split History
ARCW Split History
ARG Split History
ARTW Split History
ARW Split History
ASGN Split History
ASTC Split History
ASTE Split History
ASV Split History
ATA Split History

Also explore: APDN shares outstanding history

NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
Kingold Jewelry, Inc. (KGJI)
Aethlon Medical, Inc. (AEMD)
Aberdeen Standard Physical Gold Shares ETF (SGOL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

APDN Insider Buying

APDN Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.